Skip to main content
. 2015 Nov 14;2:10. doi: 10.1186/s40661-015-0018-x

Fig. 2.

Fig. 2

Kaplan-Meier plots of survival in patients with metastatic vaginal cancer (n = 11; median, 7.1 months; 95 % CI, 3.2–11 months) and vulvar cancer (n = 16; 4.4 months; 2.6–6.2 months) who underwent phase I trial therapy